30.3 C
Vientiane
Wednesday, July 9, 2025
spot_img
Home Blog Page 434

LONGi maintains AAA ranking in Q1 2025 PV ModuleTech Bankability Ratings

XI’AN, China, April 17, 2025 /PRNewswire/ — LONGi has announced the retention of its AAA rating in PV-Tech’s Q1 2025 PV ModuleTech bankability ratings, marking the company’s 21st consecutive quarter at this top tier and underscoring its long-term commitment to quality, innovation, financial stability and leadership in the photovoltaic industry.

LONGi maintains AAA ranking
LONGi maintains AAA ranking

The PV ModuleTech bankability ratings are derived from a thorough evaluation process that examines manufacturers across several critical dimensions, including value chain strength, production capacity, global shipment profiles, capital expenditure (capex), R&D investment and cash-flow management. LONGi’s consistent AAA status reflects not only its robust operational metrics but also its dedication to advancing solar technology.

Relying on its profound technology accumulation and advanced intelligent manufacturing advantages, LONGi has made continuous breakthroughs in HPBC technology and forward-looking R&D, and its products for utility and distributed scenarios have been implemented successively.

Since the launch of the new-generation BC products based on HPBC 2.0 in May 2024, LONGi has been winning large orders globally.

At the beginning of April, LONGi signed a 226MW Hi-MO 9 module supply agreement in Greece, which marks the largest BC utility project in Europe.

At the end of March, LONGi signed a Hi-MO X10 module supply framework agreement with a total capacity of 555MW with multiple EPC companies at the South Africa International Photovoltaic and Energy Storage Exhibition. The high-power generation per unit area and anti-shading features of the products have been highly recognized by African customers.

By the end of the first quarter of 2025, the global shipments of BC modules had exceeded 30GW, and the scale of reserved orders had exceeded 40GW.

With technological innovation as its mission, LONGi has been constantly improving the R&D of conversion efficiency in the crystalline silicon and crystalline silicon-perovskite tandem tracks. Up to now, it still holds the world records in these two major tracks.

On April 11th, LONGi announced at its Wuhu base in Anhui Province, China: Through the authoritative certification of the Institute for Solar Energy Research Hamelin (ISFH) in Germany, the photoelectric conversion efficiency of its independently developed Hybrid Interdigitated-Back-Contact (HIBC) crystalline silicon solar cell has reached 27.81%, pushing the exploration of the limits of monocrystalline silicon photovoltaic cells to a new height.

At the same time, LONGi independently developed a two-terminal crystalline silicon-perovskite tandem solar cell that has achieved a conversion efficiency of 34.85%, certified by the U.S. National Renewable Energy Laboratory (NREL), once again breaking the world record for crystalline silicon-perovskite tandem cell efficiency.

The 21 consecutive AAA ratings are not only a strong testament to LONGi’s reliability but also a footnote to LONGi’s consistent commitment to product quality, stable operation, and long-termism. In the future, LONGi will continue to enhance its technological strength and risk-resistance capabilities, and work hand in hand with global partners to create a better future.

LONGi maintains AAA ranking in Q1 2025 PV ModuleTech Bankability Ratings

XI’AN, China, April 17, 2025 /PRNewswire/ — LONGi has announced the retention of its AAA rating in PV-Tech’s Q1 2025 PV ModuleTech bankability ratings, marking the company’s 21st consecutive quarter at this top tier and underscoring its long-term commitment to quality, innovation, financial stability and leadership in the photovoltaic industry.

LONGi maintains AAA ranking
LONGi maintains AAA ranking

The PV ModuleTech bankability ratings are derived from a thorough evaluation process that examines manufacturers across several critical dimensions, including value chain strength, production capacity, global shipment profiles, capital expenditure (capex), R&D investment and cash-flow management. LONGi’s consistent AAA status reflects not only its robust operational metrics but also its dedication to advancing solar technology.

Relying on its profound technology accumulation and advanced intelligent manufacturing advantages, LONGi has made continuous breakthroughs in HPBC technology and forward-looking R&D, and its products for utility and distributed scenarios have been implemented successively.

Since the launch of the new-generation BC products based on HPBC 2.0 in May 2024, LONGi has been winning large orders globally.

At the beginning of April, LONGi signed a 226MW Hi-MO 9 module supply agreement in Greece, which marks the largest BC utility project in Europe.

At the end of March, LONGi signed a Hi-MO X10 module supply framework agreement with a total capacity of 555MW with multiple EPC companies at the South Africa International Photovoltaic and Energy Storage Exhibition. The high-power generation per unit area and anti-shading features of the products have been highly recognized by African customers.

By the end of the first quarter of 2025, the global shipments of BC modules had exceeded 30GW, and the scale of reserved orders had exceeded 40GW.

With technological innovation as its mission, LONGi has been constantly improving the R&D of conversion efficiency in the crystalline silicon and crystalline silicon-perovskite tandem tracks. Up to now, it still holds the world records in these two major tracks.

On April 11th, LONGi announced at its Wuhu base in Anhui Province, China: Through the authoritative certification of the Institute for Solar Energy Research Hamelin (ISFH) in Germany, the photoelectric conversion efficiency of its independently developed Hybrid Interdigitated-Back-Contact (HIBC) crystalline silicon solar cell has reached 27.81%, pushing the exploration of the limits of monocrystalline silicon photovoltaic cells to a new height.

At the same time, LONGi independently developed a two-terminal crystalline silicon-perovskite tandem solar cell that has achieved a conversion efficiency of 34.85%, certified by the U.S. National Renewable Energy Laboratory (NREL), once again breaking the world record for crystalline silicon-perovskite tandem cell efficiency.

The 21 consecutive AAA ratings are not only a strong testament to LONGi’s reliability but also a footnote to LONGi’s consistent commitment to product quality, stable operation, and long-termism. In the future, LONGi will continue to enhance its technological strength and risk-resistance capabilities, and work hand in hand with global partners to create a better future.

LONGi maintains AAA ranking in Q1 2025 PV ModuleTech Bankability Ratings

XI’AN, China, April 17, 2025 /PRNewswire/ — LONGi has announced the retention of its AAA rating in PV-Tech’s Q1 2025 PV ModuleTech bankability ratings, marking the company’s 21st consecutive quarter at this top tier and underscoring its long-term commitment to quality, innovation, financial stability and leadership in the photovoltaic industry.

LONGi maintains AAA ranking
LONGi maintains AAA ranking

The PV ModuleTech bankability ratings are derived from a thorough evaluation process that examines manufacturers across several critical dimensions, including value chain strength, production capacity, global shipment profiles, capital expenditure (capex), R&D investment and cash-flow management. LONGi’s consistent AAA status reflects not only its robust operational metrics but also its dedication to advancing solar technology.

Relying on its profound technology accumulation and advanced intelligent manufacturing advantages, LONGi has made continuous breakthroughs in HPBC technology and forward-looking R&D, and its products for utility and distributed scenarios have been implemented successively.

Since the launch of the new-generation BC products based on HPBC 2.0 in May 2024, LONGi has been winning large orders globally.

At the beginning of April, LONGi signed a 226MW Hi-MO 9 module supply agreement in Greece, which marks the largest BC utility project in Europe.

At the end of March, LONGi signed a Hi-MO X10 module supply framework agreement with a total capacity of 555MW with multiple EPC companies at the South Africa International Photovoltaic and Energy Storage Exhibition. The high-power generation per unit area and anti-shading features of the products have been highly recognized by African customers.

By the end of the first quarter of 2025, the global shipments of BC modules had exceeded 30GW, and the scale of reserved orders had exceeded 40GW.

With technological innovation as its mission, LONGi has been constantly improving the R&D of conversion efficiency in the crystalline silicon and crystalline silicon-perovskite tandem tracks. Up to now, it still holds the world records in these two major tracks.

On April 11th, LONGi announced at its Wuhu base in Anhui Province, China: Through the authoritative certification of the Institute for Solar Energy Research Hamelin (ISFH) in Germany, the photoelectric conversion efficiency of its independently developed Hybrid Interdigitated-Back-Contact (HIBC) crystalline silicon solar cell has reached 27.81%, pushing the exploration of the limits of monocrystalline silicon photovoltaic cells to a new height.

At the same time, LONGi independently developed a two-terminal crystalline silicon-perovskite tandem solar cell that has achieved a conversion efficiency of 34.85%, certified by the U.S. National Renewable Energy Laboratory (NREL), once again breaking the world record for crystalline silicon-perovskite tandem cell efficiency.

The 21 consecutive AAA ratings are not only a strong testament to LONGi’s reliability but also a footnote to LONGi’s consistent commitment to product quality, stable operation, and long-termism. In the future, LONGi will continue to enhance its technological strength and risk-resistance capabilities, and work hand in hand with global partners to create a better future.

Celebrate an Easter in Style at The Ritz-Carlton, Bali

BALI, Indonesia, April 16, 2025 /PRNewswire/ — The Ritz-Carlton, Bali, the premier luxury beachfront destination in Nusa Dua, invites guests to indulge in a sophisticated celebration filled with coastal elegance, gourmet dining, and unforgettable family moments.

Easter at The Ritz-Carlton, Bali
Easter at The Ritz-Carlton, Bali

Nestled along the pristine shores of Sawangan Beach, The Ritz-Carlton, Bali offers the perfect setting to embrace the joy of the season. From exclusive Easter-themed experiences to exquisite culinary delights, the hotel has curated a holiday getaway designed to delight guests of all ages.

Experience an elegant Easter Brunch, held in our oceanfront restaurant, The Beach Grill. Guests can enjoy a lavish buffet featuring locally sourced seafood and premium meats, spring-inspired dishes, and decadent desserts, accompanied by live music and stunning views.

“Our goal is to create a serene and luxurious Easter experience where families can relax, reconnect, and make memories,” said Go Kondo, General Manager of The Ritz-Carlton, Bali. “With our stunning location and thoughtful amenities, we’re proud to be the ideal destination for a coastal holiday celebration.”

Easter Brunch at The Ritz-Carlton, Bali is available on Easter Day, Sunday 20 April 2025, priced at IDR 900,000++ per person at The Beach Grill. Children aged 3 and under dine for free, and those between 4 and 12 receive 50% off.

To book your Easter stay or learn more about seasonal events, visit http://ritzcarltonbali.com/ or call +62-361-8498988.

About The Ritz-Carlton, Bali

Built on a sprawling 12.7 hectares white beach front and elevated  cliff  top  settings,  The  Ritz-Carlton, Bali feature 313 oceanfront suites and villas, enjoying the unobstructed view of the Indian Ocean and the resort’s lush garden. Completing the experiences, a glass elevator connects the cliff and the beach-front, five restaurants and bars, The Ritz-Carlton Ballroom and meeting facilities, a wedding chapel, as well as The Ritz-Carlton Spa. Ladies and gentlemen at The Ritz-Carlton, Bali is proudly presents the timeless charms of Indo-Balinese hospitality.

About The Ritz-Carlton Hotel Company, LLC

Delivering the Gold Standard in service in coveted destinations around the world, The Ritz-Carlton Hotel Company, LLC currently operates more than 120 hotels in over 35 countries and territories. From iconic urban destinations to stretches of paradise in untouched corners of the earth, The Ritz-Carlton offers the opportunity for true discovery and transformative escapes that stay with guests long after they depart. Committed to thoughtful innovation, The Ritz-Carlton encompasses two groundbreaking brand extensions, Ritz-Carlton Reserve and The Ritz-Carlton Yacht Collection. Ritz-Carlton Reserve is a collection of rare estates set apart from the world, where personalized care and cultural immersion are paramount. The Ritz-Carlton Yacht Collection translates the brand’s legendary service and hospitality for sea, reimagining the ultra-luxury cruising category. For more information or reservations, visit the company website at www.ritzcarlton.com, for the latest company updates, visit news.marriott.com and to join the live conversation, use #RCMemories and follow along on Facebook, Twitter, and Instagram. The Ritz-Carlton Hotel Company, L.L.C. is a wholly-owned subsidiary of Marriott International, Inc. (NASDAQ:MAR). The Ritz-Carlton is proud to participate in Marriott Bonvoy®, the global travel program from Marriott International. The program offers members an extraordinary portfolio of global brands, exclusive experiences on Marriott Bonvoy Moments and unparalleled benefits including complimentary nights and Elite status recognition. To enroll for free or for more information about the program, visit marriottbonvoy.com. The Ritz-Carlton is committed to supporting the destinations where it operates through Community Footprints, the company’s social and environmental responsibility program.

Galaxy Macau Signals Summer’s Arrival: Grand Resort Deck Reopens, Inviting Guests to ‘Make Waves’

Macau’s Unrivalled Skytop Waves Define a Season of Sophisticated Leisure and Aquatic Fun at the Award-winning Integrated Resort


MACAU SAR – Media OutReach Newswire – 17 April 2025 – Spring blossoms into summer, as the mercury begins its anticipated climb, with the thrill of waves calling all fun-and-sun seekers. Get ready to dive into the aquatic landscape of Galaxy Macau’s world-class luxury integrated resort—which unveils its legendary Grand Resort Deck on April 18, transforming the property into an expansive rooftop aquatic outdoor playground. Guests staying at any of the integrated resort’s eight luxury hotels can enjoy exclusive access to boundless waves and thrilling adventures. Whether conquering the exhilarating 1.5-meter swells of the world’s largest sky-high wave pool or drifting down the 575-meter Skytop Adventure Rapids, the reopening of the Grand Resort Deck marks the start of an unforgettable summer.

The world's longest 575-meter sky-high rapids, freely gliding through transparent waterslides.
The world’s longest 575-meter sky-high rapids, freely gliding through transparent waterslides.

Grand Resort Deck, Make Waves
This year, the Grand Resort Deck invites discerning global travelers and residents alike, to ‘Make Waves,’ embracing a season defined by elevated leisure, vibrant energy, and the creation of lasting memories against a backdrop of unparalleled aquatic attractions. Guests are invited to plunge into the world’s largest elevated wave pool, a feat of engineering that spans 8,000 square meters, capable of generating 1.5-meter high waves – providing genuine surf within the sightline of the Cotai skyline. Complementing these dynamic features are swathes of pristine white sand, forming a 150-meter beach that offers moments of tranquil repose. Guests can chart their own course for summer enjoyment – whether that involves the exhilaration of the wave pool, a leisurely drift along the rapids, finding quiet sanctuary in a private cabana, or being swept along a transparent slide. Younger guests can revel in the dedicated water playgrounds that offer dedicated beachside play zones for the whole family to enjoy. Whimsical play is amplified by the giant transparent aqua rollers and a kaleidoscope of spray zones.

A thrilling 9-meter-high waterslide tower delivers endless excitement.
A thrilling 9-meter-high waterslide tower delivers endless excitement.

Capture picture-perfect holiday snaps on the 150-meter-long, pristine white sand beach.
Capture picture-perfect holiday snaps on the 150-meter-long, pristine white sand beach.

Pulsating beats from poolside DJs transition the Grand Resort Deck from daytime family fun to sundown escapades. This year, the Grand Resort Deck extends its opening hours until 8 p.m., transforming this remarkable 75,000-square-meter expanse into a day-to-night spectacle, culminating in beachside stargazing atop the waves after dark.

This year, the Grand Resort Deck extends its opening hours until to 8 p.m., transforming this remarkable 75,000-square-meter expanse into a day-to-night spectacle, culminating in beachside stargazing atop the waves after dark.
This year, the Grand Resort Deck extends its opening hours until to 8 p.m., transforming this remarkable 75,000-square-meter expanse into a day-to-night spectacle, culminating in beachside stargazing atop the waves after dark.

“The Grand Resort Deck is more than an amenity; it’s a cornerstone of the Galaxy Macau award-winning integrated resort experience that comes alive during the summer. We are dedicated to creating compelling new reasons for our global guests to enjoy exceptional leisure experiences,” says Kevin Kelley, Chief Operating Officer–Macau of Galaxy Entertainment Group. “The ‘Make Waves’ theme encourages our guests to fully immerse themselves in the possibilities – from family fun to world-class wellness and sophisticated relaxation. We believe the scale, quality and sheer breadth of the Grand Resort Deck offer a compelling draw for visitors seeking a distinguished escape for the summer.”

Forbes Travel Guide Five-Star Hospitality, Tailored for All
Beyond the water, guests can expect award-winning Forbes’ Travel Guide Five Star service at Galaxy Macau—which has celebrated the accolade of having the most Forbes Travel Guide Five-Star Hotels under one roof of any luxury resort company worldwide for three years running —boasting eight distinct luxury hotel properties, including Banyan Tree Macau, Galaxy Hotel™, Hotel Okura Macau, JW Marriott Hotel Macau, The Ritz-Carlton Macau, Broadway Macau, Raffles at Galaxy Macau, and Andaz Macau. Together, they offer 5,000 unparalleled rooms, suites, and villas overlooking the Grand Resort Deck’s aquatic tropical landscape and Taipa’s glittering skyline.

Summer Glamping packages at the Grand Resort Deck for up to 8 people, including welcome snacks, drinks and much more.
Summer Glamping packages at the Grand Resort Deck for up to 8 people, including welcome snacks, drinks and much more.

At Galaxy Kidz Edutainment Center, little ones can dive into themed activities filled with fun and new things to learn. From STEAM activities, cooking classes and hand craft workshops, to endless hotel activities. Every Friday to Sunday in April and May 1–5, families can find Galaxy Kidz’s Mascot Wavey, the lovable Peacock, throughout the property’s different locations. Kids can enjoy a diverse and extensive program when staying at Galaxy Macau by joining Wavey’s fun activities, promising an exclusive gift as a reward. Little guests even can bring home delightful limited-edition merchandise from Wavey.

Galaxy Kidz provides colorful, creative play workshops for children to discover the pleasures of summer with Wavey the Peacock mascot and friends.
Galaxy Kidz provides colorful, creative play workshops for children to discover the pleasures of summer with Wavey the Peacock mascot and friends.

“Glow & Flow” Weekend Wellness Premium Packages: Neon Yoga and SUP Yoga
To elevate this unparalleled experiential getaway, from May 10 – June 7, weekend-exclusive packages (priced at MOP 468) grant access to ‘Glow Yoga Nights’ or a Stand-Up Paddleboard (SUP) Yoga Session, paired with all-day access to the Grand Resort Deck and a MOP 200 dining voucher. Neon Yoga Night is led by professional artists who adorn participants with body art, transforming yoga poses into a luminous spectacle under blacklight. SUP Yoga Sessions, guided by expert instructors, practice balance and mindfulness atop floating platforms in the wave pool. Surprise moments of wellness and fun define this summer season at the world’s largest rooftop wave pool, perfect for photo-worthy moments for the endless summer.

From May 10 - June 7, weekend-exclusive packages grant access to ‘Glow Yoga Nights’ or SUP Yoga Sessions, paired with all-day access to the Grand Resort Deck and a MOP 200 dining voucher.
From May 10 – June 7, weekend-exclusive packages grant access to ‘Glow Yoga Nights’ or SUP Yoga Sessions, paired with all-day access to the Grand Resort Deck and a MOP 200 dining voucher.

Refined Poolside Enjoyment
Crafting a personal narrative for summer, guests can savor alfresco dining at The Ritz-Carlton Pool Bar or Cabana at Banyan Tree Macau, both offering international fare with panoramic poolside views. The Pool Bar at JW Marriott serves a refreshing array of fresh juices and light bites, while The Breeze Café offers artisanal coffee for moments of poolside serenity. For sips between dips, the Surf Bar delivers curated cocktails and a diverse selection of global bites.

This summer, Galaxy Macau invites guests to ride a new wave of luxury—where every splash, slide, and sunset redefines what it means to escape in style. Whether for family getaways, friends’ reunions, or romantic retreats, the Grand Resort Deck is a signature attraction ensuring a world-class, all-in-one experience that solidifies Galaxy Macau’s unrivalled position as Asia’s leading destination for premium leisure and entertainment .

Galaxy Macau’s portfolio of 8 distinct luxury hotels offer guests complimentary access to the Grand Resort Deck.
Galaxy Macau’s portfolio of 8 distinct luxury hotels offer guests complimentary access to the Grand Resort Deck.

Hashtag: #GalaxyMacau

The issuer is solely responsible for the content of this announcement.

About Galaxy Macau Integrated Resort

Galaxy Macau™, The World-class Luxury Integrated Resort delivers the “Most Spectacular Entertainment and Leisure Destination in the World”. Developed at an investment of HK$43 billion, the property covers 1.1 million-square-meter of unique entertainment and leisure attractions that are unlike anything else in Macau. Eight award-winning world-class luxury hotels provide close to 5,000 rooms, suites and villas. They include Banyan Tree Macau, Galaxy Hotel™, Hotel Okura Macau, JW Marriott Hotel Macau, The Ritz-Carlton, Macau, Broadway Hotel, Raffles at Galaxy Macau and Andaz Macau. Unique to Galaxy Macau, the 75,000-square-meter Grand Resort Deck features the world’s longest Skytop Adventure Rapids at 575-meters, the largest Skytop Wave Pool with waves up to 1.5-meters high and 150-meters pristine white sand beach. Two five-star spas from Banyan Tree Spa Macau and The Ritz-Carlton Spa, Macau help guests relax and rejuvenate.

As the dining destination in Asia, Galaxy Macau offers a wide variety of gastronomic delights, exquisite experiences and ingredients of the finest quality with over 120 dining options from Michelin dining to authentic delicacies; Galaxy Promenade is the hottest shopping destination featuring the latest in fashion and curated experiences in Macau. Spanning over 100,000-square-meter, luxury flagship stores, lifestyle boutiques and our selection of labels are among the more than 200 world-renowned brands for a world-class shopping journey; Galaxy Cinemas, immersive thrills and luxurious comfort go hand in hand at Galaxy Cinemas. All 10 theaters are equipped with the latest audio-visual technology; CHINA ROUGE, one-of-a-kind cabaret lounge that evokes the glamor of Shanghai’s golden era with stylish entertainment and customizable surrounds; and Foot Hub, which presents the traditional art of reflexology for authentic relaxation and revitalization. For Authentic Macau Flavours and Vibrant Asian Experiences, Broadway Macau – just a 90-second walk via a bridge from Galaxy Macau, has over 35 Authentic Macau & Asian Flavours at Broadway Food Street. The 2,500-seat Broadway Theatre plays host to world-class entertainers and a diverse array of cultural events. Meeting, incentive and banquet groups are also catered to with a portfolio of unique venues in Galaxy Macau and an expert service team.

Galaxy International Convention Center (GICC) is the latest addition to the Group’s ever-expanding integrated resort precinct and will usher in a new era for the MICE industry in Macau. GICC is a world-class event venue featuring 40,000-square-meters of total flexible MICE, and the 16,000-seat Galaxy Arena – the largest indoor arena in Macau.

For more details, please visit , and .

Rhino Rescue Launches New Outdoor Product Lineup to Enhance Safety for Adventurers

LOS ANGELES, April 17, 2025 /PRNewswire/ — Rhino Rescue, a global leader in emergency preparedness solutions, recently launched its latest innovations: the Rhino Rescue Mini First Aid Kit, a compact yet comprehensive emergency kit specifically designed for high-activity outdoors, the Home First Aid Kit specifically designed for home and office use, and the Outdoor Camping First Aid Kit designed for campers and outdoor families.

photos from collaborating influencer
photos from collaborating influencer

This marks a significant step in Rhino Rescue’s expansion into the consumer market, following overwhelming demand from its community. Officially launched in late 2024, the brand’s new civilian product line is tailored for outdoor sports, travel, and home emergency preparedness—bringing tactical-grade emergency care into everyday life.

Addressing a Growing Need

According to the National Safety Council, over 3.7 million injuries requiring emergency care in 2023 were related to sports and recreational equipment. Meanwhile, a report by the American Red Cross revealed that 80% of household first aid kits are either incomplete or contain expired items.

Rhino Rescue’s new range of products addresses this critical safety gap with accessible, specialized solutions for a variety of real-life scenarios.

Product Highlights

Mini First Aid Kit

Designed for hiking, cycling, and off-road sports, this compact kit includes all essentials while remaining portable:

  • Premium Material: Weighing just 20g, it’s made from high-quality nylon for durability.
  • Ultralight & Compact: Measuring 180×100×30mm and weighing 0.45lb when fully equipped, it easily fits in any bag or backpack.
  • Comprehensive Supplies: Contains 79 emergency essentials for treating minor wounds, cuts, scrapes, burns, colds, and blisters.

In just two weeks, its Facebook video gained over 30,000 views, with users calling it “portable and practical,” making it a must-have for outdoor enthusiasts.

Home First Aid Kit

Designed for home, office, and on-the-go use, this 240-piece professional-grade first aid kit is ideal for treating minor injuries, common illnesses, and unexpected emergencies.

  • Comprehensive Coverage: Includes 240 essential items such as a thermometer, antibiotic ointments, burn gel, and cold packs to treat minor injuries and common emergencies.
  • Versatile & Compact: Perfect for homes, offices, schools, dorms, cars, camping, and travel—delivering preparedness in any setting, all in a compact 7.9 x 6.5 x 4.5-inch design.
  • Smart Organization: Features thoughtfully arranged compartments and a removable center layer for quick, easy access to supplies.

“I keep one in my kitchen and one in my car—it’s so well-stocked and easy to use,” says Julia T., a home user.

Outdoor Camping First Aid Kit

Designed for campers and outdoor families, this kit includes essential medical supplies like burn gel, a CPR face shield, splints, and a digital thermometer. It features camping-specific items to address various outdoor injuries without adding extra weight.

Influencer Jamie Curry commented, “My wife was injured during a camping trip, and I didn’t have a single first aid item with me. That’s when I realized how essential these kits are.”

“These products were born directly from user feedback. Our goal is to help every individual—whether in the city or the wilderness—be better prepared. Every second counts during an emergency, and we want to make sure people are ready when it matters most,” said Owen Zhuang, Product Director at Rhino Rescue.

Founded in 2010, Rhino Rescue is a global leader in emergency medical solutions, serving both professional responders and the civilian market. With a mission to make high-quality, tactical-grade emergency tools accessible for everyone, Rhino Rescue is redefining the emergency preparedness experience through professional expertise and user-friendly design.

Wherever you are—urban streets or remote trails—Rhino Rescue has your back.

For more information about the brand, visit the website at: https://rhinorescuestore.com/collection

mini First Aid Kit
mini First Aid Kit

Outdoor Camping First Aid Kit
Outdoor Camping First Aid Kit

Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano

Highlights

  • Clarity has signed a commercial-scale agreement with Nusano, Inc. (“Nusano”) for supply of copper-64 (Cu-64 or 64Cu) isotope.
  • The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capacity, which translates into more than 18,000 patient doses per day at 200 MBq per dose, with a 48-hour shelf-life, far in excess of commercial scale demands across multiple large indications.
  • The copper-64 supply from Nusano will complement Clarity’s existing network of US-based suppliers to ensure seamless, abundant production of this diagnostic isotope as the Company is progressing a number of late-stage clinical trials and fast approaching commercialisation.
  • Nusano plans to begin production of other medical isotopes, such as copper-67 and actinium-225, both of which are used in Clarity’s products, in 2025-2026.

SYDNEY, April 17, 2025 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop and commercialise next-generation products that improve treatment outcomes for people with cancer, is pleased to announce the signing of a commercial-scale Supply Agreement for copper-64 with Nusano.

Nusano’s 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected to begin production in 2025 with copper-64 isotope supply planned to commence in early 2026. The accelerator-based proprietary technologies employed by Nusano are particularly well suited for cost-effective mass production of copper-64. The Nusano facility is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capacity, which translates into more than 18,000 patient doses per day at 200 MBq per dose, with a 48-hour shelf-life, well in excess of commercial-scale demands across multiple large oncology indications in line with Clarity’s commercialisation strategy. Nusano is also developing in-house production of the target material for copper-64 manufacturing, nickel-64 (Ni-64), and plans to commence production of copper-67 (Cu-67 or 67Cu) and actinium-225 (Ac-225 or 225Ac) isotopes in 2025-2026. Both of these isotopes are used in Clarity’s pipeline of theranostic products in development.

Clarity’s Executive Chairperson, Dr Alan Taylor, commented, “The signing of this Supply Agreement with Nusano will complement Clarity’s existing network of US-based copper-64 suppliers, providing capacity to ensure abundant and seamless supply of the isotope. As Clarity is generating exceptional data in a number of late-stage clinical trials, we now also have a cost-effective, large-scale supply strategy locked in for the commercial roll-out of our Targeted Copper Theranostics (TCTs) in the largest healthcare market in the world, the US. This Agreement is an important part of a larger commercial manufacturing strategy, which we will continue implementing as we get closer to the filing of New Drug Applications (NDA) with the US Food and Drug Administration (FDA).

“The ability to make isotopes and products in the US for the treatment of the American people is an important advantage in the current geo-political and economic environment. By building a supply chain that is fully integrated, from high-volume isotope production, to centralised product manufacture, to delivering these ready-to-use diagnostics to imaging sites in every state of the US on time and on demand, we are aiming to build a model that is impervious to economic and political instability.

“In large oncology indications, such as prostate-specific membrane antigen (PSMA) positron emission tomography (PET) diagnostics (which Clarity is addressing with our key product, SAR-bisPSMA), ensuring stable, abundant and seamless supply of isotopes is crucial for a successful commercial launch.

“We have seen first-hand from the current generation of radio-diagnostics that efficient and timely product supply can make or break the adoption of the products and their expansion in the oncology practice. The current market leaders in PSMA PET imaging face several limitations associated with their short half-life (less than 2 hours vs. 12.7 hours for copper-64). These include short shelf-lives, restricted availability throughout the imaging site’s workday, and narrow imaging windows. At Clarity, our strategy is straightforward: we are determined to overcome these limitations and lay a strong foundation for the successful roll-out of TCTs globally.

“Our goal is to take radiopharmaceuticals to the next level by building a reliable and accessible supply that is consistent with the big pharma oncology model and deliver advantages to patients, their treating clinicians and imaging sites. Under this central manufacture model, the imaging sites will receive the copper-64 based diagnostics on demand, at any time and in volumes consistent with the rapidly growing demand of this blockbuster market. The clinicians have the added flexibility to administer the copper-based diagnostics and image patients over a significantly longer timeframe than what the current products allow. This translates into more flexibility for patient imaging and potentially higher lesion detection sensitivity that could lead to better identification of cancer lesions, helping to determine the best course of treatment for oncology patients.

“With our SAR-bisPSMA product generating a lot of exciting data and 3 US FDA Fast Track Designations granted for this product1,2,3 for accelerating its development, locking in commercial-scale supply of copper-64 means we are now closer than ever to changing the paradigm of prostate cancer diagnosis, ensuring no man is left waiting for a PSMA PET scan,” said Dr Taylor.

Nusano’s Chief Executive Officer, Chris Lowe, commented, “Nusano is commercialising a breakthrough radioisotope production platform in 2025 capable of producing more than 25 radioisotopes for life science applications, including copper-64, copper-67 and actinium-225. We are excited to enter into a Supply Agreement with Clarity for copper-64 to enable their clinical and commercial efforts with a dependable supply of radioisotopes from our world-class production facility in Utah.”

Additional Disclosure

The Supply Agreement is effective as of 16 April 2025 and is for an initial period of 3 years with automatic renewal for successive 2-year periods. Cancellation provisions are aligned with industry standard rates.

About Clarity Pharmaceuticals

Clarity is a clinical stage radiopharmaceutical company focused on the treatment of serious diseases. The Company is a leader in innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancers.

www.claritypharmaceuticals.com

About Nusano

Nusano is a privately held physics company committed to bringing supply stability and innovation to the rapidly emerging and critically undersupplied medical radioisotopes market, and to serving industrial and commercial markets dependent on reliable access to high quality radioisotopes for their products and services. Driven by the company’s proprietary ion source, the Nusano production platform will generate radioisotopes in volumes and varieties exceeding other production methods. Nusano’s breakthrough technologies are poised to help supply the fight against cancer and enable innovation across multiple industries. For more, please visit nusano.com.

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor     

Catherine Strong

Executive Chairperson

Investor/Media Relations

ataylor@claritypharm.com   

c.strong@morrowsodali.com 

+61 406 759 268

Nusano                                        

Scott Larrivee

Joyce Allaire

Media Relations

Investor Relations

scott.larrivee@nusano.com 

jallaire@lifesciadvisors.com

1-608-345-6629     

1-212-915-2569

References

  1. Clarity Pharmaceuticals. Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA. https://www.claritypharmaceuticals.com/news/fast-track/
  2. Clarity Pharmaceuticals. Clarity receives U.S. FDA Fast Track Designation for 64Cu-SAR-bisPSMA in biochemical recurrence of prostate cancer. https://www.claritypharmaceuticals.com/news/ftd-2/
  3. Clarity Pharmaceuticals. Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA. https://www.claritypharmaceuticals.com/news/ftd-67cu-sarbispsma/

This announcement has been authorised for release by the Executive Chairperson.

ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone

Showcasing at ASCRS 2025:

  • More than 2 million cases planned with ZEISS VERACITY Surgery Planner: Growing use of one of the leading digital planning solutions for cataract surgery in the U.S. is a testament to the increased adoption of the ZEISS Cataract Workflow digital solutions by surgeons.
  • ZEISS MEL 90 broadens refractive treatment portfolio: U.S. availability of both the ZEISS MEL 90 and ZEISS VISUMAX 800 extends the company’s LVC market leadership with treatments for myopia, hyperopia, and mixed astigmatism.
  • Enhanced cataract portfolio with DORC and FCI: Showcasing cataract solutions from DORC and FCI for the first time in the ZEISS booth #1501.

JENA, Germany and DUBLIN, Calif., April 17, 2025 /PRNewswire/ — ZEISS Medical Technology will celebrate the rapid adoption of digital cataract solutions and showcase newly available refractive treatment technology at the American Society of Cataract and Refractive Surgery (ASCRS) conference from April 25 – 27 in Los Angeles, CA. ZEISS marks a major milestone in the U.S. with more than 2 million digitally planned cases using the ZEISS VERACITY Surgery Planner,1 one of the leading digital planning solutions for cataract surgery, which serves as a testament to the growing number of surgeons discovering the benefits of digital workflows in the delivery of patient care and treatments.

ZEISS VERACITY Surgery Planner
ZEISS VERACITY Surgery Planner

“The digital era continues to grow at a rapid pace. Ophthalmologists are increasingly realizing the significant benefits of using digital workflows as the backbone of their medical practices,” says Magnus Reibenspiess, Head of Strategic Business Unit Ophthalmology at ZEISS Medical Technology. “ZEISS has much to celebrate at ASCRS this year, including our continued U.S. leadership in digital innovation and ongoing commitment to improving patient care across both the cataract and refractive markets.”

Additionally, the ZEISS Refractive Workflow will showcase for the first time both the VISUMAX® 800 with SMILE® pro from ZEISS and the MEL® 90 from ZEISS, helping to further broaden a surgeon’s refractive business with improved patient attraction and positive clinical outcomes. Lastly, for the first time, DORC and FCI, both ZEISS companies, are set to present their portfolio of cataract surgical solutions in the ZEISS booth, showcasing the extended benefits of ZEISS’s surgical portfolio.

More than 2 million cases planned using ZEISS VERACITY Surgery Planner reflects growing digital adoption by U.S. cataract surgeons

ZEISS VERACITY Surgery Planner is one of the top digital planning solutions for cataract surgery in the U.S. today with thousands of users logging in to plan their surgical cases, pulling data from most modern EMRs, 19 different diagnostic devices, and optional data sources like patient questionnaires, in order to make data-driven informed decisions designed to drive better patient outcomes in clinics and ORs.

At ASCRS, ZEISS will celebrate the significant milestone of its cloud-based ZEISS VERACITY Surgery Planner, with more than 2 million cases planned. A recent study showed that with the ZEISS Cataract Workflow powered by ZEISS VERACITY Surgery Planner, surgeons and staff can save up to 60% of their time per eye compared to traditional paper planning.2

Kerry Solomon, MD, from Carolina Eye Care Physicians, one of the creators of VERACITY prior to its acquisition by ZEISS in 2017, says, “Today we’re up to 2 million plans, unbelievable! When we first started developing this solution, I absolutely envisioned we’d get to where we are today, and I’m thrilled with where we’re at!”

In addition to proven efficiency gains, new research abstracts presented at this year’s ASCRS showcase excellent refractive accuracy and clinical outcomes when adopting the ZEISS Cataract Workflow:

  1. Steven C. Schallhorn, MD, ABO, will present a clear benefit of reducing postoperative astigmatism by implanting toric IOLs in patients with lower preoperative corneal astigmatism, leveraging cataract outcomes obtained from VERACITY Surgery Planner’s database of 50,850 eyes with preoperative corneal astigmatism between 0.75D and 1.50D.
  2. Luke Rebenitsch, MD, ABO, will present a comparison of refractive outcomes in a large cohort of 49,057 eyes undergoing cataract surgery with toric IOL implantation where the use of the ZEISS CALLISTO eye system resulted in significant improvements in terms of post-op refractive outcomes compared to a manual marking approach.
  3. Kamran M. Riaz, MD, ABO, will present an analysis of the refractive accuracy of two biometers in a cohort of 222 eyes with prior laser vision correction and implantation of toric multifocal IOLs, highlighting the significantly better performance of total keratometry with the IOLMaster 700.

Enhanced refractive treatment portfolio enables a higher standard of refractive patient care with both the ZEISS VISUMAX 800 and ZEISS MEL 90

ZEISS continues to set high standards in refractive patient care in the U.S. with the availability of both the ZEISS VISUMAX 800 and ZEISS MEL 90. For the first time, the ZEISS MEL 90 will be showcased in the U.S. at ASCRS, extending ZEISS’s LVC market leadership with treatment for myopia, hyperopia, and mixed astigmatism.

“The FDA approval of the ZEISS MEL 90 excimer laser is a game changer for refractive surgery in the U.S. I am particularly impressed by the system’s ability to simplify treatment planning while delivering highly predictable and tissue-conserving results. This approval marks an exciting chapter for surgeons and patients alike,” says Dr. John Doane, Refractive Surgeon, Discover Vision Centers, Kansas City, MO (USA).

The MEL® 90 from ZEISS aims to offer U.S. surgeons a fast, reliable, and streamlined surgery experience, complementing the VISUMAX® 800 with SMILE® pro from ZEISS to help further broaden a surgeon’s refractive business with improved patient attraction and positive clinical outcomes.

The ZEISS VISUMAX 800 with ZEISS SMILE pro software enables faster treatment, creating the lenticule in less than 10 seconds thanks to a faster laser pulse repetition rate of 2 MHz.3 The ZEISS femtosecond laser also provides greater flexibility for the surgeon and patient, with a smaller footprint and compatibility with a variety of patient beds, adapting to the clinical environment to provide cutting-edge technology without compromise.

Showcasing the benefits of ZEISS’s surgical portfolio to help meet the evolving clinical challenges of surgeons in the U.S.

ZEISS will showcase for the first time together in the ZEISS booth key solutions from DORC and FCI.  This will feature the DORC EVA NEXUS surgical system for cataract and phaco-vitrectomy surgeries. It will also include the DORC VisionBlue® anterior stain, a trusted choice in more than 10 million cataract surgeries since its introduction. As the only FDA-approved trypan blue stain for anterior applications, it is also authorized for staining Descemet’s membrane and trabecular meshwork.  Additionally, the ZEISS booth will feature the FDA-approved Eyejet® 20C from Morcher®, built on the gold standard preloaded Eyejet® system and designed to prevent toric IOLs rotation, providing maximum toric benefits.

ZEISS will showcase its latest offerings and new innovations at the American Society of Cataract and Refractive Surgery (ASCRS) conference from April 25-27, 2025, in Los Angeles, CA, at booth #1501.

For more information, visit www.zeiss.com/med

1 Data on file.
2 Gujral, Tarika, and John Hovanesian. “Cataract Surgical Planning Using Online Software vs Traditional Methods.” Clinical Ophthalmology (Auckland, N.Z.), U.S. National Library of Medicine, 28 July 2021.
3 Data on file, myopia with optical zone 6.5 mm. 

Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals’ content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support. 

Contact for investors
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: investors.meditec@zeiss.com

Contact for the press
Frank Smith
Head of Global Communications Ophthalmology
Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: press.med@zeiss.com

www.zeiss.com/newsroom          

Brief Profile

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).

The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG’s shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading groups in the optical and optoelectronic industries.

For further information visit: www.zeiss.com/med

ZEISS MEL 90 Excimer Laser
ZEISS MEL 90 Excimer Laser